Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 3/20 | 0.46 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.45 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.43 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.43 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.42 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.42 |
| ▸ | ITGAL | P20701 | 1/20 | 0.42 |
| ▸ | BACE1 | P56817 | 6/20 | 0.42 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.42 |
| ▸ | GRPR | P30550 | 1/20 | 0.41 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28354383 | 1.00 | REN (0.46) | RENSLC15A2ACE2AGTR1AGTR2 | |
| SCHEMBL29918691 | 0.85 | SLC15A2 (0.48) | RENSLC15A2AGTR1AGTR2ITGB2 | |
| SCHEMBL21529464 | 0.82 | BACE1 (0.42) | BACE1BACE2 | |
| SCHEMBL31187019 | 0.82 | BACE1 (0.42) | BACE1BACE2 | |
| SCHEMBL21955470 | 0.80 | REN (0.44) | RENSLC15A2ACE2ITGB2ICAM1 | |
| SCHEMBL23380976 | 0.79 | LNPEP (0.42) | RENSLC15A2ITGB2ICAM1ITGAL | |
| SCHEMBL28964060 | 0.78 | BACE1 (0.59) | RENAGTR1AGTR2BACE1 | |
| SCHEMBL21955489 | 0.78 | LNPEP (0.43) | RENSLC15A2ITGB2ICAM1ITGAL | |
| SCHEMBL23380979 | 0.78 | LNPEP (0.43) | RENSLC15A2ITGB2ICAM1ITGAL | |
| SCHEMBL31464223 | 0.77 | SLC15A2 (0.47) | SLC15A2GRPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12208150-B2 | Antimicrobial skincare composition | Shielded, Beauty, LLC (US) | 2025-01-28 | — | — | US | claimed |
| WO-2024237777-A1 | COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING SKIN PIGMENTATION | WINNOX COSMECEUTICS SDN. BHD. (MY) | 2024-11-21 | — | — | WO | claimed |
| US-20240041743-A1 | SYNERGISTIC TETRAPEPTIDE COMBINATION | BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) | 2024-02-08 | — | — | US | claimed |
| US-20190336429-A1 | SYNERGISTIC TETRAPEPTIDE COMBINATION | BASF CORPORATION | 2019-11-07 | — | — | US | claimed |
| WO-2026099555-A1 | COSMETIC USE OF AN EXTRACT OF LYSIMACHIA CHRISTINAE | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2026-05-15 | — | — | WO | disclosed |
| US-20260083663-A1 | BOTANICAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF | ARKANSAS STATE UNIV JONESBORO (US) | 2026-03-26 | — | — | US | disclosed |
| EP-4687830-A1 | COSMETIC USES OF A HYDROLYSED EXTRACT OF SILYBUM MARIANUM SEED CAKE | BASF Beauty Care Solutions France SAS (FR) | 2026-02-11 | — | — | EP | disclosed |
| EP-4340807-B1 | HAIR COLOR COMPOSITIONS FOR MITIGATING COLOR LOSS | LUBRIZOL ADVANCED MAT INC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-20250304630-A1 | POLYPEPTIDES HAVING OSMOPROTECTIVE ACTIVITY, COMPOSITIONS THEREOF AND USES THEREOF | DELAVIE SCIENCES, LLC | 2025-10-02 | — | — | US | disclosed |
| US-12419824-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| EP-4573103-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | Lubrizol Advanced Materials, Inc. (US) | 2025-06-25 | — | — | EP | disclosed |
| EP-4262741-B1 | COSMETIC USES OF A HIPPOPHAE RHAMNOIDES CAKE HYDROLYSATE | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2025-06-25 | — | — | EP | disclosed |
| WO-2022129775-A1 | COSMETIC, NUTRACEUTICAL OR DERMATOLOGICAL USE OF A LACTOBACILLUS CRISPATUS STRAIN AND/OR OF A COMPOSITION COMPRISING SAME | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022129750-A1 | COSMETIC USES OF A HIPPOPHAE RHAMNOIDES CAKE HYDROLYSATE | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2022-06-23 | — | — | WO | disclosed |
| US-11364193-B2 | Cosmetic use of a Nephelium lappaceum extract | BASF BEAUTY CARE SOLUTIONS FRANCE S.A.S. (FR) | 2022-06-21 | — | — | US | disclosed |
| US-20220183950-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2022-06-16 | — | — | US | disclosed |
| EP-3212688-B1 | THERMOPLASTIC POLYURETHANE FILM FOR DELIVERY OF ACTIVE AGENTS TO SKIN SURFACES | LUBRIZOL ADVANCED MAT INC (US) | 2022-04-13 | — | — | EP | disclosed |
| WO-2022069844-A1 | NOVEL USE OF A PEPTIDE TO IMPROVE THE COMFORT OF SKIN AND/OR MUCOUS MEMBRANES AND/OR THE APPEARANCE OF DANDER | BASF BEAUTY CARE SOLUTIONS FRANCE SAS (FR) | 2022-04-07 | — | — | WO | disclosed |
| WO-2022029579-A1 | EMULSIFIER COMPOSITION FOR PERSONAL CARE FORMULATION | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2022-02-10 | — | — | WO | disclosed |
| US-20190336429-A1 | SYNERGISTIC TETRAPEPTIDE COMBINATION | BASF CORPORATION | 2019-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083663-A1 | BOTANICAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF | SAMM50, SYMPK, CD69 | REN 2725/4885SLC15A2 3509/4885ACE2 2626/4885 |
| US-20220183950-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | TYR, TELO2, MTX2 | REN 2740/4885SLC15A2 1022/4885ACE2 3028/4885 |
| US-12419824-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | TYR, TELO2, MTX2 | REN 2740/4885SLC15A2 1022/4885ACE2 3028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.